penpulimab,sintilimab
eli lilly,innovent biologics,akesobio,sino biopharmaceuticals
['sintilimab']
 i think they could be but after the failure of the to approve #sintilimab then it s unlikely as china only io drugs are mostly licensed on trials conducted exclusively in china and not multi-regional 
Medical Oncology fellow & Pharmacist at @imperialcollege @ImperialSandC doing PhD in #cancer #microbiome -interest in health policy, drug development & @rovers